Financials
- Market Capitalization 39.6 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry 전문의약품 및 제네릭 의약품 제조업체
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-0.16
주가매출액비율
86.42
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 4281 | INCR Intercure Ltd. - ordinary shares | 0.95 USD | -2.06% | -3.06% | +5.56% | -38.71% | 51.95 M USD | ||
| 4353 | SCYX SCYNEXIS, Inc. - Common Stock | 4.48 USD | +2.28% | +1.82% | +5.41% | +453.09% | 44.49 M USD | ||
| 4453 | ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 0.71 USD | -8.97% | +1.43% | -5.33% | -70.90% | 33.65 M USD | ||
| 4550 | CPHI China Pharma Holdings, Inc. Common Stock | 0.60 USD | -3.23% | -9.09% | -24.05% | -9.24% | 24.31 M USD |